Carboplatin and Docetaxel Followed by Epstein-Barr Virus Cytotoxic T Lymphocytes (CADEN)

This study is currently recruiting participants.
Verified January 2014 by Baylor College of Medicine
Texas Children's Hospital
Houston Methodist Hospital
Center for Cell and Gene Therapy, Baylor College of Medicine
M.D. Anderson Cancer Center
Information provided by (Responsible Party):
Chrystal Louis, Baylor College of Medicine Identifier:
First received: August 4, 2009
Last updated: February 3, 2014
Last verified: January 2014
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2016
  Estimated Primary Completion Date: January 2015 (Final data collection date for primary outcome measure)